Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma-Reference-Cited by-同舟云学术

Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma

Published:2016-08-23 Issue:39 Volume:7 Page:63629-63639
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Eberhardt Allison¹,Hansen Jeanne N.¹,Koster Jan²,Lotta Louis T.¹,Wang Simeng¹,Livingstone Emmett¹,Qian Kun³,Valentijn Linda J.²,Zheng Yujun George³,Schor Nina F.¹,Li Xingguo¹

Affiliation:

1. Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, 14642, USA

2. Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands

3. Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, The University of Georgia, Athens, Georgia 30602, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the dynamics and interactions of the N-myc transactivation domain through solution NMR;2024-05-23

2. The Tangential Dialogue Between Science and Medicine: A Case in Point;Pediatric Neurology;2024-04

3. RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells;Oncology Reports;2023-11-21

4. The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application;Biomedicine & Pharmacotherapy;2023-11

5. The initiation of mammalian embryonic transcription: to begin at the beginning;Trends in Cell Biology;2023-05